Garry Watts was appointed to the Board on 23 August 2013.
He is the chairman of Spire Healthcare Group UK Limited, retiring chairman of BTG plc and a member of the audit committee of Coca-Cola European partners plc. Garry is a chartered accountant and a former partner at KPMG.
In 1996 he joined Medeva plc as its finance director and in 2000, following a merger with Celltech Chiroscience, he was appointed as a director of Celltech Group plc and became CEO of its Celltech Medeva division.
Garry joined SSL International plc in 2001 as its finance director and was subsequently appointed as its Chief Executive Officer from 2004 to 2010. In addition to his executive roles, Garry was a non-executive member of the board, and chairman of the audit and risk committee, of the UK's Medicines and Healthcare Products Regulatory Agency from 1991 to 2008 (for which he was awarded an MBE).
Between 2004 and 2008, he was a non-executive director and chairman of the audit committee of Protherics plc, and during 2007 and 2008 he was a member of the Institute of Chartered Accountants' Corporate Governance Committee. Garry is a Fellow of the Institute of Chartered Accountants in England and Wales.
Chief Executive Officer
Nic Budden joined Foxtons in 2005 as its Chief Operating Officer.
Prior to joining Foxtons, Nic had an international career in business development, operations, marketing, strategy and finance, having held positions at BT Group plc (1990 to 1997), Cable & Wireless Group (1997 to 2002) and Severn Trent Group (2003 to 2005).
Nic holds a degree in economics from the University of Essex.
Chief Financial Officer
Mark joined Foxtons as Chief Financial Officer in November 2016. Prior to joining Foxtons, Mark held a number of positions at FTSE 250 recruitment business Hays plc. After early roles in internal audit and as Head of M&A, Mark became European Finance Director in 2006, in which he was responsible for businesses across 15 countries. In 2011 Mark was appointed as Group Financial Controller, a position in which he acted as Deputy Group Finance Director and held until joining Foxtons. Mark has extensive international experience across many areas of finance and over ten years' experience working in an agency business.
Mark qualified as a Chartered Accountant with Deloitte and holds an economics degree from the University of Birmingham.
Senior Independent Non-Executive Director
Ian Barlow was appointed to the Board on 23 August 2013.
He is a non-executive director of Smith & Nephew plc and The Brunner Investment Trust PLC and the lead non-executive director of HM Revenue & Customs. He is also chairman of The Racecourse Association Limited, a board member of the China-Britain Business Council and a trustee of the Historic Royal Palaces.
Ian is a past chairman of WSP Group plc. Ian retired from KPMG LLP in 2008 as senior partner, London. Ian is a chartered accountant and a chartered tax adviser. He holds an MA in engineering science from the University of Cambridge.
Independent Non-Executive Director
Sheena has over 28 years HR experience, leading global HR functions across FTSE 100 and 250 companies. She is currently Group HR Director of Smiths Group plc, and previously Group HR Director at Aggreko plc, BBA Aviation plc and SSL International plc, starting off her career at GEC plc. Her HR experience covers business transformations including acquisitions and disposals. Leadership development and remuneration design have been a particular focus throughout her career.
She undertook her BA and postgraduate studies in Management Science at the University of Manchester.
Independent Non-Executive Director
Alan has extensive experience as a non-executive director and is currently the senior independent non-executive director of Perpetual Income and Growth Investment Trust plc. He is also the Chairman of The Remuneration Consultants Group, an associate fellow of Saïd Business School, University of Oxford, and an honorary visiting professor at Cass Business School, City, University of London.
Alan was the senior independent non-executive director and chairman of the remuneration committee of Rentokil Initial plc until May 2017, and the senior independent non-executive board member and remuneration committee chairman of The Competition and Markets Authority until March 2019. He was formerly chairman of Fat Face Group Limited, chief executive of HMV Group Plc, managing director of Waterstones, and an executive director of WH Smith Plc, and he previously held non-executive directorships at The Office of Fair Trading, Somerfield Plc and Wilson Bowden Plc.